CONFERENCES

      Society for Neuroscience Conference

      The Society for Neuroscience (SfN) hosts annual conferences focusing on understanding the brain and the nervous system, with topics ranging from big data analysis to molecular therapies. The event is aimed at scientists, academics, researchers, healthcare professionals, regulators, and industry experts, and provides a forum for sharing knowledge and collaborating to learn about new research developments and raise awareness of the importance of brain research.

       

      Neuroscience 2021

      Date

      Nov 08, 2021 - Nov 11, 2021

      Location

      Chicago, USA

      Online

      This meeting is the largest neuroscience conference in the world and is attended by over 30,000 neuroscientists from 80 countries. Sessions and events at the annual meeting are designed to provide attendees with a range of opportunities, including scientific enrichment, career development, and professional networking.

      Neuroscience 2019

      Date

      Oct 19, 2019 - Oct 23, 2019

      Location

      Chicago, USA

      SfN's 49th annual meeting, the world's largest neuroscience conference for scientists and physicians devoted to understanding the brain and nervous system, expects more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience. 

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.